Planning, approval and implementation of a clinical investigation – Experiences of the startup Skinuvita
In order for medical devices and IVDs to receive a CE marking, proof of their safety and performance is required. In most cases, there is not enough clinical data available for innovative products – for example from similar products – so that it is necessary to...
MII x OSORA – Faster go-to-market and why the medical device is now at the end of the roadmap
Case Study | Projekt mit OSORA medical GmbH OSORA has gathered a variety of starting points for market entry in order to position the technology for bone healing simulation. Market segments exist in the areas of education and training, implant development and...
MII x Fysor – How an idea became the product “Apelvo”
Case Study | Project with Fysor GmbH An innovative product idea with a pure training approach can be launched on the market as a lifestyle product. But such a business model must also take into account the requirements and opportunities of the 4Cs in order to be...
MII x sync2brain – From business model development to a certified legal manufacturer
Case Study | Project with sync2brain GmbH Medical innovations often emerge from research and are driven by a scientific perspective. However, in order for such product ideas to actually reach patients, a market-oriented view must be developed. This was the challenge...
The 4C Alumni Gathering 2023 – Driving medical innovation together
A strong network, peer-to-peer learning and collaboration with established partners in the healthcare industry are important factors for the success of MedTech startups. In order to support startup projects and young companies on this level, we invite alumni of the 4C...
Seeking investment? – The relevance of the 4Cs from an investor’s perspective
Questions about the 4Cs and their interrelations play a central role in the development of a plausible business model in the healthcare sector. Obviously, networked 4C knowledge is also a key advantage in fundraising. We spoke to Christian Kraft, Director M&A and...
Selective contracts as an opportunity for startups to enter the market? – Insights by Experts of BKK Linde
74 million people in Germany, and thus almost 90 % of the population, have statutory health insurance. So when it comes to the question of how to bring a new, innovative product to market, medtech start-ups often find a quick answer in the statutory health insurers...
MII x Erbe Elektromedizin – Bringing valuable medical innovations into use despite strategy change
Case Study | Project with Erbe Elktromedizin GmbH Highly innovative companies are often spoilt for choice: which technologies have potential and strengthen the overall strategy? Which ideas are valuable but create inefficiencies in implementation and should not be...
Recent Comments